Towards establishing a multiple sclerosis biobank in Jordan

References

• Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet 1972;1(7762):1240–1.
   PubMed Web of Science ®Google Scholar
• Barcellos LF, Oksenberg JR, Begovich AB, HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003;72(3): 710–6.
   PubMed Web of Science ®Google Scholar
• Gregory SG, Schmidt S, Seth P, Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007;39(9):1083–91.
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium, Sawcer S, Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476(7359):214–9.
   PubMed Web of Science ®Google Scholar
• Ebers G, and goodin D. Multiple sclerosis: epidemiology, genetics and environmental factors. Proceedings of the MS Forum Modern Management Workshop; 2007 Feb; Wiesbaden, Germany.
   Google Scholar
• Simpson S Jr, Blizzard L, Otahal P, Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011;82:1132–41.
   PubMed Web of Science ®Google Scholar
• El-Salem K, Al-Shimmery E, Horany K, Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 2006;253:1210–6.
   PubMed Web of Science ®Google Scholar
• Benamer HT, Ahmed ES, Al-Din AS, Grosset DG. Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review. J Neurol Sci 2009;278:1–4.
   PubMed Web of Science ®Google Scholar
• Ollier W, Sprosen T, Peakman T. UK Biobank: from concept to reality. Pharmacogenomics 2005;6:639–46.
   PubMed Web of Science ®Google Scholar
• Myhr KM, Grytten N, Aarseth JH. The Norwegian Multiple Sclerosis Registry and Biobank. Acta Neurol Scand Suppl 2012;(195):20–3.
   PubMedGoogle Scholar
• Andersen O. From the Gothenburg Cohort to the Swedish Multiple Sclerosis Registry. Acta Neurol Scand Suppl 2012;(195):13-9.
   PubMedGoogle Scholar
• Ahram M, Othman A, Shahrouri M. Public perception towards biobanking in Jordan. Biopreserv Biobank 2012a;10: 361–5.
   PubMed Web of Science ®Google Scholar
• Ahram M, Othman A, Shahrouri M. Public support and consent preference for biomedical research and biobanking in Jordan. Eur J Hum Genet 2012b;21:567–70.
   PubMed Web of Science ®Google Scholar
• Ahram M, Othman A, Shahrouri M, Mustafa E. Factors influencing public participation in biobanking. Eur J Hum Genet 2013 (Epub ahead of print).
   Google Scholar
• Polman CV, Reingold SC, Edan G, Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol. 2005;58:840–6.
   PubMed Web of Science ®Google Scholar
• al-Din AS, el-Khateeb M, Kurdi A, Multiple sclerosis in Arabs in Jordan. J Neurol Sci 1995;131:144–9.
   PubMed Web of Science ®Google Scholar
• Pittock SJ, McClelland RL, Mayr WT, Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol. 2004;56:303–6.
   PubMed Web of Science ®Google Scholar
• Ahram M, El-Omar A, Baho Y, Lubad MA. Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients. Acta Neurol Scand. 2009;120(6):430–5.
   PubMed Web of Science ®Google Scholar
• Pugliatti M, Rosati G, Carton H, The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006;13(7):700–22.
   PubMed Web of Science ®Google Scholar
• World Health Organization and Multiple Sclerosis International Federation Atlas: Multiple Sclerosis Resources in the World 2008. Geneva, Switzerland: World Health Organization; 2008. Available from: http://www.who.int/entity/mental_ health/neurology/Atlas_MS_WEB.pdf [last accessed 5 Jan, 2014].
   Google Scholar
• Department of Statistics. Estimated population of the kingdom by sex and age group, at End-year 2011. Available from: http://www.dos.gov.jo/dos_home_a/main/2004/2011/2-5.pdf [last accessed 5 Jan, 2014].
   Google Scholar
• Melas PA, Sjöholm LK, Forsner T, Examining the public refusal to consent to DNA biobanking: empirical data from a Swedish population-based study. J Med Ethics 2010;36:93–8.
   PubMed Web of Science ®Google Scholar
• Tupasela A, Sihvo S, Snell K, Attitudes towards biomedical use of tissue sample collections, consent, and biobanks among Finns. Scand J Public Health 2010;38:46–52.
   PubMed Web of Science ®Google Scholar
• Beskow LM, Dean E. Informed consent for biorepositories: assessing prospective participants’ understanding and opinions. Cancer Epidemiol Biomarkers Prev 2008;17:1440–51.
   PubMed Web of Science ®Google Scholar
• Cousins G, McGee H, Ring L, Public perceptions of biomedical research: a survey of the general population in Ireland. Dublin: Health Research Board; 2005.
   Google Scholar
• Hoeyer K, Olofsson BO, Mjörndal T, Lynöe N. Informed consent and biobanks: a population-based study of attitudes towards tissue donation for genetic research. Scand J Public Health 2004;32:224–9.
   PubMed Web of Science ®Google Scholar
• Willison DJ, Keshavjee K, Nair K, Computerization of medical practices for the enhancement of therapeutic effectiveness investigators. Patients’ consent preferences for research uses of information in electronic medical records: interview and survey data. BMJ 2003;326:373.
   PubMed Web of Science ®Google Scholar
• Bookman EB, Langehorne AA, Eckfeldt JH, Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. Am J Med Genet 2006;140:1033–40.
   PubMed Web of Science ®Google Scholar
• Shalowitz DI, Miller FG. Communicating the results of clinical research to participants: attitudes, practices, and future directions. PLoS Med 2008;5:e91.
   PubMed Web of Science ®Google Scholar
• Forsberg JS, Hansson MG, Eriksson S. Changing perspectives in biobank research: from individual rights to concerns about public health regarding the return of results. Eur J Hum Genet 2009;17:1544–49.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis, an expanded disability status scale (EDSS). Neurol 1983;33:1444–52.
   PubMed Web of Science ®Google Scholar
• Betsou F, Barnes R, Burke T, Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 2009;18:1017–25.
   PubMed Web of Science ®Google Scholar
• Betsou F, Lehmann S, Ashton G, Standard preanalytical coding for biospecimens: defining the sample PREanalytical code. Cancer Epidemiol Biomarkers Prev 2010;19:1004–11.
   PubMed Web of Science ®Google Scholar